<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>31</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Gupta, D.</AUTHOR>
		<AUTHOR>Jetton, T. L.</AUTHOR>
		<AUTHOR>Mortensen, R. M.</AUTHOR>
		<AUTHOR>Duan, S. Z.</AUTHOR>
		<AUTHOR>Peshavaria, M.</AUTHOR>
		<AUTHOR>Leahy, J. L.</AUTHOR>
	</AUTHORS>
	<YEAR>2008</YEAR>
	<TITLE>In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter</TITLE>
	<SECONDARY_TITLE>J Biol Chem</SECONDARY_TITLE>
	<VOLUME>283</VOLUME>
	<NUMBER>47</NUMBER>
	<PAGES>32462-70</PAGES>
	<DATE>Nov 21</DATE>
	<ISBN>0021-9258 (Print)</ISBN>
	<ACCESSION_NUMBER>18718916</ACCESSION_NUMBER>
	<KEYWORDS>
		<KEYWORD>Insulin-Secreting Cells</KEYWORD>
		<KEYWORD>Hyperglycemia/genetics</KEYWORD>
		<KEYWORD>Humans</KEYWORD>
		<KEYWORD>Homeodomain Proteins/*genetics</KEYWORD>
		<KEYWORD>*Gene Expression Regulation</KEYWORD>
		<KEYWORD>Base Sequence</KEYWORD>
		<KEYWORD>Animals</KEYWORD>
		<KEYWORD>Trans-Activators/*genetics</KEYWORD>
		<KEYWORD>Sequence Homology, Nucleic Acid</KEYWORD>
		<KEYWORD>Response Elements</KEYWORD>
		<KEYWORD>*Promoter Regions, Genetic</KEYWORD>
		<KEYWORD>PPAR gamma/*metabolism</KEYWORD>
		<KEYWORD>Molecular Sequence Data</KEYWORD>
		<KEYWORD>Mice, Transgenic</KEYWORD>
		<KEYWORD>Mice</KEYWORD>
		<KEYWORD>Male</KEYWORD>
		<KEYWORD>Islets of Langerhans/metabolism</KEYWORD>
		<KEYWORD>Sequence Homology</KEYWORD>
		<KEYWORD>Genetic</KEYWORD>
		<KEYWORD>Transgenic</KEYWORD>
		<KEYWORD>Nucleic Acid</KEYWORD>
		<KEYWORD>*Promoter Regions</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>We reported that peroxisome proliferator-activated receptor gamma (PPARgamma) transcriptionally regulates the beta-cell differentiation factor pancreatic duodenal homeobox (PDX)-1 based on in vitro RNA interference studies. We have now studied mice depleted of PPARgamma within the pancreas (PANC PPARgamma(-/-)) created by a Cre/loxP recombinase system, with Cre driven by the pdx-1 promoter. Male PANC PPARgamma(-/-) mice were hyperglycemic at 8 weeks of age (8.1+/-0.2 mM versus 6.4+/-0.3 mM, p=0.009) with islet cytoarchitecture and pancreatic mass of islet beta-cells that were indistinguishable from the controls. Islet PDX-1 mRNA (p=0.001) and protein levels (p=0.003) were lowered 60 and 40%, respectively, in tandem with impaired glucose-induced insulin secretion and loss of thiazolidinedione-induced increase in PDX-1 expression. We next identified a putative PPAR-response element (PPRE) in the mouse pdx-1 promoter with substantial homology to the corresponding region of the human PDX-1 promoter. Electrophoretic mobility supershift assays with nuclear extracts from beta-cell lines and mouse islets, also in vitro translated PPARgamma and retinoid X receptor, and chromatin immunoprecipitation analysis demonstrated specific binding of PPARgamma and retinoid X receptor to the human and mouse pdx-1 x PPREs. Transient transfection assays of beta-cells with reporter constructs of mutated PPREs showed dramatically reduced pdx-1 promoter activity. In summary, we have presented in vivo and in vitro evidence showing PPARgamma regulation of pdx-1 transcription in beta-cells, plus our results support an important regulatory role for PPARgamma in beta-cell physiology and thiazolidinedione pharmacology of type 2 diabetes.</ABSTRACT>
	<NOTES>DK56818/DK/NIDDK NIH HHS/United StatesDK66635/DK/NIDDK NIH HHS/United StatesIn VitroJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States</NOTES>
	<URL>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18718916</URL>
</RECORD>
</RECORDS></XML>
